
Regeneron Pharmaceuticals Inc
NASDAQ:REGN

Wall Street
Price Targets
REGN Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
REGN
is 824.33 USD
with a low forecast of 540.35 USD and a high forecast of 1 063.65 USD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Regeneron Pharmaceuticals Inc
For the last 8 years the
compound annual growth rate for
Regeneron Pharmaceuticals Inc's operating income is
16%.
The projected
CAGR
for the next 3 years is
13%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is REGN's stock price target?
Price Target
824.33
USD
According to Wall Street analysts, the average 1-year price target for
REGN
is 824.33 USD
with a low forecast of 540.35 USD and a high forecast of 1 063.65 USD.
What is Regeneron Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
5%
For the last 8 years the
compound annual growth rate for
Regeneron Pharmaceuticals Inc's revenue is
14%.
The projected
CAGR
for the next 3 years is
5%.
What is Regeneron Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
Regeneron Pharmaceuticals Inc's operating income is
16%.
The projected
CAGR
for the next 3 years is
13%.
What is Regeneron Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Regeneron Pharmaceuticals Inc's net income is
22%.
The projected
CAGR
for the next 3 years is
7%.